Connor Blair
Research Fellow · Peptide Drug Discovery & Development
University of GlasgowAbout
Dr. Connor Blair is a Research Fellow at the University of Glasgow, specializing in cardiovascular and metabolic health. His work focuses on peptide-based therapies targeting protein-protein interactions for diseases with high unmet clinical needs.
Education:
- BSc (Hons) Neuroscience
- MRes in Biomedical Sciences
- PhD in Molecular Pharmacology
Research Interests:
Connor’s research emphasizes peptide drug discovery, protein-protein interaction modulation, and pharmacological interventions for cancer and neurodegenerative diseases. His studies explore how disrupting specific protein complexes can yield novel therapeutic strategies.
Grants & Funding:
- Novo Nordisk (2025–2026): Evaluating DRx-174 for metabolic protection
- MRC (2024–2025): DRx-992 for TP53 mutant neuroblastoma
- EPSRC (2023–2024): Optimizing c-RAF inhibitor peptides
Key Themes in Publications:
His articles consistently address targeted peptide therapies, phosphodiesterase regulation, and oncogenic signaling pathways. Recent work highlights PDE4/PDE8A inhibitors for cancer and Alzheimer’s disease.
Find Connor Blair elsewhere
Related Searches
You Might Also Like
- GGeorge BaillieUniversity of Glasgow · Professor
- AAngie SinUniversity of Glasgow · Researcher
Andrew E. AplinThomas Jefferson University · Professor- NNicholas M LevinsonUniversity of Minnesota Twin Cities · Associate Professor
- KKrishna YallaUniversity of Glasgow · Researcher
- MMatthew P. ConnorUniversity of Pennsylvania · Assistant Professor